Patents by Inventor Susan Fotheringham

Susan Fotheringham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening method
    Patent number: 10012652
    Abstract: This invention relates to a novel screening method that identifies simple molecular markers that are predictive of whether a particular disease condition is responsive to a specific treatment. Also, a method of diagnosing the susceptibility of an individual suffering from a disease to treatment with an HDAC inhibitor is provided. Also provided is a method of treating a proliferative disease or a condition which involves a change in cell differentiation or growth rate in a patient.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: July 3, 2018
    Assignee: OXFORD UNIVERSITY INNOVATION LIMITED
    Inventors: Nicholas B. La Thangue, Susan Fotheringham
  • SCREENING METHOD
    Publication number: 20170219594
    Abstract: This invention relates to a novel screening method that identifies simple molecular markers that are predictive of whether a particular disease condition is responsive to a specific treatment. Also, a method of diagnosing the susceptibility of an individual suffering from a disease to treatment with an HDAC inhibitor is provided. Also provided is a method of treating a proliferative disease or a condition which involves a change in cell differentiation or growth rate in a patient.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 3, 2017
    Inventors: Nicholas B. La Thangue, Susan Fotheringham
  • Screening method
    Patent number: 9347103
    Abstract: This invention relates to a novel screening method that identifies simple molecular markers that are predictive of whether a particular disease condition is responsive to a specific treatment. Also, a method of diagnosing the susceptibility of an individual suffering from a disease to treatment with an HDAC inhibitor is provided. Also provided is a method of treating a proliferative disease or a condition which involves a change in cell differentiation or growth rate in a patient.
    Type: Grant
    Filed: June 16, 2014
    Date of Patent: May 24, 2016
    Assignee: ISIS Innovation Limited
    Inventors: Nicholas B. La Thangue, Susan Fotheringham
  • SCREENING METHOD
    Publication number: 20140369999
    Abstract: This invention relates to a novel screening method that identifies simple molecular markers that are predictive of whether a particular disease condition is responsive to a specific treatment. Also, a method of diagnosing the susceptibility of an individual suffering from a disease to treatment with an HDAC inhibitor is provided. Also provided is a method of treating a proliferative disease or a condition which involves a change in cell differentiation or growth rate in a patient.
    Type: Application
    Filed: June 16, 2014
    Publication date: December 18, 2014
    Inventors: Nicholas B. La Thangue, Susan Fotheringham
  • Screening method
    Patent number: 8784806
    Abstract: This invention relates to a novel screening method that identifies simple molecular markers that are predictive of whether a particular disease condition is responsive to a specific treatment. Also, a method of diagnosing the susceptibility of an individual suffering from a disease to treatment with an HDAC inhibitor is provided. Also provided is a method of treating a proliferative disease or a condition which involves a change in cell differentiation or growth rate in a patient.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: July 22, 2014
    Assignee: Isis Innovation Limited
    Inventors: Nicholas B. La Thangue, Susan Fotheringham
  • Screening Method
    Publication number: 20090311244
    Abstract: This invention relates to a novel screening method that identifies simple molecular markers that are predictive of whether a particular disease condition is responsive to a specific treatment. Also, a method of diagnosing the susceptibility of an individual suffering from a disease to treatment with an HDAC inhibitor is provided. Also provided is a method of treating a proliferative disease or a condition which involves a change in cell differentiation or growth rate in a patient.
    Type: Application
    Filed: March 27, 2007
    Publication date: December 17, 2009
    Applicant: ISIS INNOVATION LIMITED
    Inventors: Nicholas B. La Thangue, Susan Fotheringham